CELLYAN BIOTECHNOLOGY CO-A (HKPD:NASDAQ)

$0.5419 0.002 (0.3704%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 56

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed CELLYAN BIOTECHNOLOGY CO-A (HKPD:NASDAQ) News Sources

Wall Street Set to Open Higher Friday; Nonfarm Payrolls Fall Well Short of Forecasts

05-09-2025

yahoo.com

One Hong Kong Pharma Digital Technology Holdings Insider Raised Their Stake In The Previous Year

29-11-2025

yahoo.com

Hong Kong Pharma Digital Announced Results of 2025 Annual Meeting of Stockholders

17-12-2025

yahoo.com

Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Bid Price Deficiency

16-01-2026

yahoo.com

CELLYAN BIOTECHNOLOGY CO-A (HKPD:NASDAQ) Sentiment Trend

0 25 50 75 100 65 53 53 52 05-09-2025 29-11-2025 17-12-2025 16-01-2026 #1 #2 #3 #4 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

CELLYAN BIOTECHNOLOGY CO-A (HKPD:NASDAQ) FAQs

toggle

What is the current price of CELLYAN BIOTECHNOLOGY CO-A (HKPD:NASDAQ)?

The current price of CELLYAN BIOTECHNOLOGY CO-A (HKPD:NASDAQ) is $0.5419.


toggle

CELLYAN BIOTECHNOLOGY CO-A (HKPD:NASDAQ) absolute price change since previous trading day?

The absolute price change of CELLYAN BIOTECHNOLOGY CO-A (HKPD:NASDAQ) since the previous trading day is $0.002.


toggle

CELLYAN BIOTECHNOLOGY CO-A (HKPD:NASDAQ) percentage price change since previous trading day?

The percentage price change of CELLYAN BIOTECHNOLOGY CO-A (HKPD:NASDAQ) since the previous trading day is 0.3704%.


toggle

What is the most recent average sentiment score for CELLYAN BIOTECHNOLOGY CO-A (HKPD:NASDAQ)?

The most recent average sentiment score for CELLYAN BIOTECHNOLOGY CO-A (HKPD:NASDAQ) is 56 out of 100.


toggle

What is the most recent average sentiment for CELLYAN BIOTECHNOLOGY CO-A (HKPD:NASDAQ)?

The most recent sentiment for CELLYAN BIOTECHNOLOGY CO-A (HKPD:NASDAQ) is .


SEC-8K** Filing Available For CELLYAN BIOTECHNOLOGY CO-A (HKPD:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.